Cardiac Targeting Peptide CTP – Other Categories
The pathology of coronary heart disease (CHD) and ischemia are linked to the health of endothelial cells in the heart.- However, providing molecular therapies specifically into myocardium remains elusive. The cardiac targeting peptide (CTP) was shown to specifically transduce cardiomyocytes as it is a cationic PTD. This peptide can be used as a conjugate to deliver molecules specifically to the heart. This can be a crucial tool for research into therapeutic drug delivery for ischemic attacks and infarctions. This peptide is research quality and therefore for research purposes only, and not for use in a therapeutic setting.
Technical specification
| Sequence : | H-APWHLSSQYSRT-OH | |
| MW : | 1.431.7 g/mol | |
| Purity : | > 95% | |
| Counter-Ion : | TFA Salts | |
| Delivery format : | Lyophilized |
Price
| Product | Size | Price € | Price $ |
| CRB1001631-0.5 mg | 0.5 mg | 141€ | 170$ |
| CRB1001631-1 mg | 1 mg | 193€ | 232$ |